Straumann Holding AG (SAUHY)
12.88
-0.10
(-0.77%)
USD |
OTCM |
May 24, 16:00
Straumann Shareholders Equity (Quarterly): 2.186B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.186B |
| June 30, 2023 | 2.106B |
| June 30, 2023 | 2.106B |
| December 31, 2022 | 1.997B |
| June 30, 2022 | 1.831B |
| June 30, 2022 | 1.831B |
| December 31, 2021 | 1.636B |
| June 30, 2021 | 1.481B |
| June 30, 2021 | 1.481B |
| December 31, 2020 | 1.379B |
| June 30, 2020 | 1.110B |
| June 30, 2020 | 1.110B |
| December 31, 2019 | 1.407B |
| June 30, 2019 | 1.273B |
| June 30, 2019 | 1.273B |
| December 31, 2018 | 1.220B |
| June 30, 2018 | 1.093B |
| June 30, 2018 | 1.093B |
| December 31, 2017 | 1.106B |
| June 30, 2017 | 683.69M |
| June 30, 2017 | 683.69M |
| Date | Value |
|---|---|
| December 31, 2016 | 622.74M |
| June 30, 2016 | 738.61M |
| June 30, 2016 | 738.61M |
| December 31, 2015 | 612.05M |
| June 30, 2015 | 609.84M |
| June 30, 2015 | 609.84M |
| December 31, 2014 | 745.16M |
| June 30, 2014 | 739.38M |
| June 30, 2014 | 739.38M |
| December 31, 2013 | 711.44M |
| June 30, 2013 | 634.16M |
| June 30, 2013 | 634.16M |
| December 31, 2012 | 659.06M |
| June 30, 2012 | 671.76M |
| June 30, 2012 | 671.76M |
| December 31, 2011 | 683.45M |
| June 30, 2011 | 794.14M |
| December 31, 2010 | 744.18M |
| June 30, 2010 | 607.89M |
| December 31, 2009 | 613.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.110B
Minimum
Jun 2020
2.186B
Maximum
Dec 2023
1.614B
Average
1.481B
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 160.35M |
| CRISPR Therapeutics AG | 2.084B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -8.834M |
| Molecular Partners AG | 186.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.955B |
| Total Liabilities (Quarterly) | 1.766B |
| Debt to Equity Ratio | 0.1089 |
| Current Ratio | 1.947 |
| Net Debt Paydown Yield | -0.31% |